RxElite, Inc.
RXEI
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -29.23M | -21.43M | -22.00M | -17.17M | -14.41M |
| Total Depreciation and Amortization | 1.98M | 1.39M | 868.00K | 437.00K | 267.10K |
| Total Amortization of Deferred Charges | 4.18M | 2.78M | 1.49M | -- | -- |
| Total Other Non-Cash Items | 13.39M | 7.01M | 9.46M | 6.35M | 5.44M |
| Change in Net Operating Assets | 5.80M | -604.20K | -1.52M | -2.99M | -8.22M |
| Cash from Operations | -3.89M | -10.85M | -11.70M | -13.37M | -16.92M |
| Capital Expenditure | -7.86M | -7.54M | -8.44M | -1.85M | -982.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -186.50K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -7.86M | -7.54M | -8.63M | -1.85M | -982.40K |
| Total Debt Issued | 13.50M | 13.50M | 10.50M | 10.50M | 460.00K |
| Total Debt Repaid | -381.00K | -913.10K | -895.00K | -925.90K | -1.28M |
| Issuance of Common Stock | 0.00 | 10.36M | 13.46M | 15.71M | 19.60M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -416.90K | -2.29M | -2.36M | -2.36M | -1.97M |
| Cash from Financing | 12.70M | 20.66M | 20.70M | 22.92M | 16.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 949.20K | 2.26M | 380.00K | 7.71M | -1.10M |